Data raises questions about long-term effects of GLP-1 therapies
Eos SENOLYTIX says new preclinical findings highlight body composition and healthy aging as the next frontier in obesity medicine. A…
Eli Lilly’s Retatrutide Shows Strong Weight Loss, Nears Diabetes Approval
Retatrutide’s Triple Action Targets Metabolism Eli Lilly’s retatrutide drug is making waves in the metabolic health field. It…